Yantai Zhenghai Bio-Tech Co Ltd Total Assets
Yantai Zhenghai Bio-Tech Co Ltd total assets. Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) holds total assets worth CN¥1.00 Billion CNY (≈ $146.75 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Yantai Zhenghai Bio-Tech Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Yantai Zhenghai Bio-Tech Co Ltd (2012–2025)
Total assets of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2025. This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's total assets have evolved over time, based on quarterly financial data. See 300653 live share price for real-time trading data and today's change.
Yantai Zhenghai Bio-Tech Co Ltd - Asset Composition Analysis
Yantai Zhenghai Bio-Tech Co Ltd Total Assets Breakdown (December 2025)
Yantai Zhenghai Bio-Tech Co Ltd total assets breakdown as of December 2025. Yantai Zhenghai Bio-Tech Co Ltd's total assets of CN¥1.00 Billion consist of 74.5% current assets and 25.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 6.3% |
| Accounts Receivable | CN¥57.18 Million | 5.8% |
| Inventory | CN¥29.55 Million | 3.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥29.96 Million | 3.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Yantai Zhenghai Bio-Tech Co Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yantai Zhenghai Bio-Tech Co Ltd's current assets represent 74.5% of total assets in 2025, an increase from 63.7% in 2012.
- Cash Position: Cash and equivalents constituted 6.3% of total assets in 2025, down from 33.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 6.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 5.8% of total assets.
Yantai Zhenghai Bio-Tech Co Ltd Competitors by Total Assets
Key competitors of Yantai Zhenghai Bio-Tech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
|
USA | $641.76 Million |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Bavarian Nordic
CO:BAVA
|
Denmark | Dkr14.95 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
Yantai Zhenghai Bio-Tech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.42 | 8.70 | 4.34 |
| Quick Ratio | 8.07 | 8.38 | 4.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥660.48 Million | CN¥663.03 Million | CN¥432.41 Million |
Yantai Zhenghai Bio-Tech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Yantai Zhenghai Bio-Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.07 |
| Latest Market Cap to Assets Ratio | 0.38 |
| Asset Growth Rate (YoY) | 0.5% |
| Total Assets | CN¥984.62 Million |
| Market Capitalization | $370.07 Million USD |
Valuation Analysis
Below Book Valuation: The market values Yantai Zhenghai Bio-Tech Co Ltd's assets below their book value (0.38x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Yantai Zhenghai Bio-Tech Co Ltd's assets grew by 0.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Yantai Zhenghai Bio-Tech Co Ltd (2012–2025)
The table below shows the annual total assets of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥984.62 Million ≈ $144.08 Million |
+0.46% |
| 2024-12-31 | CN¥980.11 Million ≈ $143.42 Million |
-6.99% |
| 2023-12-31 | CN¥1.05 Billion ≈ $154.21 Million |
+6.78% |
| 2022-12-31 | CN¥986.90 Million ≈ $144.42 Million |
+6.24% |
| 2021-12-31 | CN¥928.92 Million ≈ $135.93 Million |
+15.32% |
| 2020-12-31 | CN¥805.54 Million ≈ $117.88 Million |
+11.81% |
| 2019-12-31 | CN¥720.45 Million ≈ $105.42 Million |
+23.37% |
| 2018-12-31 | CN¥583.98 Million ≈ $85.46 Million |
+10.02% |
| 2017-12-31 | CN¥530.82 Million ≈ $77.68 Million |
+104.84% |
| 2016-12-31 | CN¥259.14 Million ≈ $37.92 Million |
+29.34% |
| 2015-12-31 | CN¥200.35 Million ≈ $29.32 Million |
+143.41% |
| 2014-12-31 | CN¥82.31 Million ≈ $12.04 Million |
+5.81% |
| 2013-12-31 | CN¥77.79 Million ≈ $11.38 Million |
-15.24% |
| 2012-12-31 | CN¥91.78 Million ≈ $13.43 Million |
-- |
About Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral restoration membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etching agent, dental pit and fissure sealant, active biol… Read more